The non-carrier phase 3 trials for Bapi are now complete according to clinicaltrials.gov. I suspect we will hear about topline data within the next 6-8 weeks. I sure hope Intellect gets the US patent for the n-terminus before the data is released.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.